Sunway Healthcare Holdings Bhd (SHH), the healthcare arm of Sunway Bhd, is confident that investors will see value in its initial public offering (IPO) despite concerns that its proposed pricing may be relatively high compared to industry peers.
SHH launched its IPO prospectus last Friday, revealing plans to raise up to RM2.86 billion through the offering. The healthcare group is targeting a maximum IPO price of RM1.45 per share, which, if achieved, would give the company an estimated market capitalisation of RM16.68 billion, based on 11.5 billion shares.
The company is scheduled to list on the Main Market of Bursa Malaysia on March 18. According to SHH, the IPO will support its growth initiatives and further strengthen its position in the Malaysian healthcare sector.
Market analysts have noted that while the pricing may appear elevated relative to peers, the company’s track record, market position, and growth potential make the IPO an attractive opportunity for investors seeking exposure to the healthcare sector.
Sunway Healthcare Holdings operates a broad network of hospitals, medical centres, and ancillary healthcare services, making it one of the largest private healthcare providers in Malaysia. The funds raised from the IPO are expected to support expansion plans, enhance infrastructure, and improve service offerings across its healthcare network.
The IPO also marks a significant milestone for Sunway Bhd, reinforcing its commitment to strengthening its healthcare segment while providing retail and institutional investors an opportunity to participate in the company’s growth story.
